Dolby Laboratories, Inc. (DLB) Financials
DLB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 3.2 billion | 563.9 million |
| March 31, 2026 | 3.2 billion | 622.4 million |
| Dec. 31, 2025 | 3.2 billion | 589.3 million |
| Sept. 30, 2025 | 3.2 billion | 595.8 million |
DLB Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 147.7 million | 31.0 million |
| March 31, 2026 | 46.4 million | 30.7 million |
| Dec. 31, 2025 | 49.4 million | 37.2 million |
| Sept. 30, 2025 | 101.0 million | 31.1 million |
DLB Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | 29.2 million |
| March 31, 2026 | 94.9 million |
| Dec. 31, 2025 | 53.7 million |
| Sept. 30, 2025 | 49.7 million |
DLB Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 670.0 million | - | 47.5 million |
| March 31, 2026 | 594.7 million | - | 49.7 million |
| Dec. 31, 2025 | 644.6 million | - | 40.6 million |
| Sept. 30, 2025 | 702.6 million | - | 38.9 million |
DLB Shares Outstanding
DLB Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 19.8 million | 65.7 million | 160.7 million | 85.1 million |
| March 31, 2026 | 46.1 million | 63.7 million | 172.1 million | 96.2 million |
| Dec. 31, 2025 | 5.4 million | 69.1 million | 161.8 million | 91.6 million |
| Sept. 30, 2025 | 21.8 million | 67.5 million | 164.2 million | 90.5 million |
DLB Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 305.0 million | 40.3 million |
| March 31, 2026 | 395.6 million | 44.7 million |
| Dec. 31, 2025 | 346.7 million | 43.2 million |
| Sept. 30, 2025 | 307.0 million | 39.5 million |
DLB Revenue by Segment
DLB
List: Contenders
Price: $58.46
Dividend Yield: 2.45%
Forward Dividend Yield: 2.43%
Payout Ratio: 55.05%
Dividend Per Share: 1.44 USD
Earnings Per Share: 2.36 USD
P/E Ratio: 26
Exchange: NYQ
Sector: Industrials
Industry: Specialty Business Services
Country: United States
Volume: 759000
Ebitda: 104.8 millionMarket Capitalization: 5.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR3: 9.70%
DGR5: 8.55%
DGR10: 12.82%